← Back to Search

Nocebo Education for ADHD Awareness

N/A
Recruiting
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No current intake of medication to treat a psychiatric disorder (e.g., antidepressants)
No existing diagnosis of ADHD, or history/current diagnosis of any other neurological/psychiatric disorder
Must not have
Diagnosis of ADHD or any other neurological/psychiatric disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change 1 week
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to investigate the impact of a mental health awareness workshop on young adults. The first part of the study will look at whether the workshop leads to self-diagnosis and worsening symptoms in healthy young

Who is the study for?
This trial is for healthy young adults interested in mental health. It's designed to see if learning about ADHD can unintentionally make people think they have it or worsen symptoms, and if teaching about nocebo effects (harm from negative expectations) might prevent this.
What is being tested?
The study compares three groups: one attends a sleep workshop, another an ADHD info workshop, and the third an ADHD workshop that includes education on nocebo effects. Participants will report self-diagnosed ADHD immediately after and one week post-workshop, plus any symptoms after a week.
What are the potential side effects?
There are no traditional medical side effects involved since this isn't testing a drug or medical treatment. However, potential 'side effects' could include increased self-diagnosis of ADHD or perceived worsening of symptoms due to heightened awareness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not currently taking any psychiatric medications.
Select...
I have not been diagnosed with ADHD or any other neurological/psychiatric disorder.
Select...
My vision and hearing are normal, or corrected to be normal.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with ADHD or another neurological/psychiatric condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change 1 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and change 1 week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Self-diagnosis with ADHD
Self-reported ADHD symptoms
Secondary study objectives
Depressive and Anxiety Symptoms
Memory Failures

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: ADHD information workshop with nocebo educationExperimental Treatment1 Intervention
Group II: ADHD information workshopExperimental Treatment1 Intervention
Group III: Sleep and dreams workshopActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
718 Previous Clinical Trials
1,042,252 Total Patients Enrolled
6 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
865 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
~144 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top